Michael Crowley's Insider Trades & SAST Disclosures
Michael Crowley's most recent trade in Lamb Weston Holdings Inc was a trade of 57 Common Stock done at an average price of $54.7 . Disclosure was reported to the exchange on April 11, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Michael Crowley.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lamb Weston Holdings Inc | Michael Christopher Crowley | President, North America | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.74 per share. | 11 Apr 2025 | 57 | 4,758 (0%) | 0% | 54.7 | 3,120 | Common Stock |
| Hagerty Inc - Ordinary Sha... | F. Michael Crowley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 13,828 | 42,302 | - | 0 | Class A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 159.32 per share. | 14 Mar 2025 | 3,000 | 11,171 (0%) | 0% | 159.3 | 477,960 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 3,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Sale of securities on an exchange or to another person at price $ 247.06 per share. | 14 Mar 2025 | 3,000 | 8,171 (0%) | 0% | 247.1 | 741,184 | Bio-Rad A Common Stock |
| Boston Beer Co., Inc. - Or... | Michael J. Crowley | Chief Sales Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 8,207 | 10,947 (0%) | 0% | 0 | Class A Common | |
| Boston Beer Co., Inc. - Or... | Michael J. Crowley | Chief Sales Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 243.77 per share. | 01 Mar 2025 | 170 | 2,740 (0%) | 0% | 243.8 | 41,441 | Class A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2024 | 3,456 | 3,456 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 751 | 7,324 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 751 | 2,254 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 557 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 557 | 8,454 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 520 | 1,042 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 520 | 7,576 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 434 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 434 | 8,052 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 405 | 406 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 405 | 7,763 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 334.31 per share. | 01 Sep 2024 | 283 | 8,171 (0%) | 0% | 334.3 | 94,610 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 268 | 7,056 (0%) | 0% | 337.3 | 90,402 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 218 | 7,358 (0%) | 0% | 337.3 | 73,536 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 155 | 7,897 (0%) | 0% | 337.3 | 52,285 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 337.32 per share. | 01 Sep 2024 | 145 | 7,618 (0%) | 0% | 337.3 | 48,911 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Sale of securities on an exchange or to another person at price $ 281.91 per share. | 13 Jun 2024 | 369 | 6,573 (0%) | 0% | 281.9 | 104,023 | Bio-Rad A Common Stock |
| Hagerty Inc - Ordinary Sha... | F. Michael Crowley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 9,836 | 28,474 | - | 0 | Class A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 3,535 | 3,535 | - | - | Non-Qualified Stock Option (right to buy) | |
| Boston Beer Co., Inc. - Or... | Michael J. Crowley | Chief Sales Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 1,348 | 2,910 (0%) | 0% | 0 | Class A Common | |
| Boston Beer Co., Inc. - Or... | Michael J. Crowley | Chief Sales Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 308.14 per share. | 01 Mar 2024 | 152 | 1,562 (0%) | 0% | 308.1 | 46,837 | Class A Common Stock |
| Bio-Rad Laboratories Inc. ... | Crowley Michael | EVP, GBL Commercial Operations | Sale of securities on an exchange or to another person at price $ 336.00 per share. | 27 Feb 2024 | 3,000 | 6,942 (0%) | 0% | 336 | 1,008,000 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 3,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc. ... | Crowley Michael | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 215.98 per share. | 27 Feb 2024 | 3,000 | 9,942 (0%) | 0% | 216.0 | 647,940 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Sale of securities on an exchange or to another person at price $ 305.10 per share. | 28 Nov 2023 | 642 | 6,942 (0%) | 0% | 305.1 | 195,874 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 3,005 | 3,005 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 600 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 600 | 7,882 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 557 | 557 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 557 | 7,484 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 520 | 1,562 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 520 | 6,560 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 433 | 434 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 433 | 7,077 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 405 | 811 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 405 | 6,785 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 298 | 7,584 (0%) | 0% | 394.6 | 117,591 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 202 | 7,282 (0%) | 0% | 394.6 | 79,709 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 180 | 6,380 (0%) | 0% | 394.6 | 71,028 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 150 | 6,927 (0%) | 0% | 394.6 | 59,190 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 141 | 6,644 (0%) | 0% | 394.6 | 55,639 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Sale of securities on an exchange or to another person at price $ 379.39 per share. | 15 Jun 2023 | 500 | 6,040 (0%) | 0% | 379.4 | 189,695 | Bio-Rad A Common Stock |
| Hagerty Inc - Ordinary Sha... | F. Michael Crowley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 10,297 | 18,638 | - | 0 | Class A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 6,838 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 6,536 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 600 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 557 | 6,177 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 557 | 1,114 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 433 | 5,770 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 433 | 867 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 298 | 6,540 (0%) | 0% | 478.3 | 142,539 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 298 | 6,238 (0%) | 0% | 478.3 | 142,539 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 241 | 5,936 (0%) | 0% | 478.3 | 115,275 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 150 | 5,620 (0%) | 0% | 478.3 | 71,748 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 2,082 | 2,082 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 405 | 1,216 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 405 | 5,478 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 486.25 per share. | 01 Sep 2022 | 141 | 5,337 (0%) | 0% | 486.2 | 68,561 | Bio-Rad A Common Stock |
| Hagerty Inc - Ordinary Sha... | F. Michael Crowley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 8,341 | 8,341 | - | 0 | Class A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 600 | 5,371 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 600 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 806.32 per share. | 07 Sep 2021 | 298 | 5,073 (0%) | 0% | 806.3 | 240,283 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 600 | 1,200 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 600 | 5,069 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 600 | 4,767 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 600 | 600 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 557 | 1,671 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 557 | 4,444 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 819.70 per share. | 03 Sep 2021 | 298 | 4,771 (0%) | 0% | 819.7 | 244,271 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 819.70 per share. | 03 Sep 2021 | 298 | 4,469 (0%) | 0% | 819.7 | 244,271 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 819.70 per share. | 03 Sep 2021 | 277 | 4,167 (0%) | 0% | 819.7 | 227,057 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 1,621 | 1,621 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 1,621 | 1,621 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 433 | 1,300 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 433 | 4,102 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 825.77 per share. | 01 Sep 2021 | 215 | 3,887 (0%) | 0% | 825.8 | 177,541 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2021 | 3,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 139.56 per share. | 09 Aug 2021 | 3,000 | 6,669 (0%) | 0% | 139.6 | 418,680 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Sale of securities on an exchange or to another person at price $ 754.80 per share. | 09 Aug 2021 | 2,570 | 4,099 (0%) | 0% | 754.8 | 1,939,836 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Sale of securities on an exchange or to another person at price $ 755.72 per share. | 09 Aug 2021 | 430 | 3,669 (0%) | 0% | 755.7 | 324,960 | Bio-Rad A Common Stock |
| Associated Banc-Corp. | Michael T. Crowley | Director | Grant, award, or other acquisition of securities at price $ 22.92 per share. | 15 Mar 2021 | 52 | 732,102 (0%) | 0% | 22.9 | 1,192 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Michael T. Crowley | Director | Grant, award, or other acquisition of securities at price $ 22.92 per share. | 15 Mar 2021 | 40 | 732,050 (0%) | 0% | 22.9 | 917 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Michael T. Crowley | Director | Grant, award, or other acquisition of securities at price $ 18.06 per share. | 01 Feb 2021 | 6,644 | 728,717 (0%) | 0% | 18.1 | 119,991 | Common Stock $0.01 Par Value |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Sale of securities on an exchange or to another person at price $ 580.67 per share. | 15 Dec 2020 | 374 | 3,669 (0%) | 0% | 580.7 | 217,171 | Bio-Rad A Common Stock |
| Associated Banc-Corp. | Michael T. Crowley | Director | Grant, award, or other acquisition of securities at price $ 16.79 per share. | 15 Dec 2020 | 67 | 722,073 (0%) | 0% | 16.8 | 1,125 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Michael T. Crowley | Director | Grant, award, or other acquisition of securities at price $ 16.78 per share. | 15 Dec 2020 | 55 | 722,006 (0%) | 0% | 16.8 | 923 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Michael T. Crowley | Director | Grant, award, or other acquisition of securities at price $ 13.27 per share. | 15 Sep 2020 | 83 | 721,883 (0%) | 0% | 13.3 | 1,101 | Common Stock $0.01 Par Value |
| Associated Banc-Corp. | Michael T. Crowley | Director | Grant, award, or other acquisition of securities at price $ 13.26 per share. | 15 Sep 2020 | 68 | 721,951 (0%) | 0% | 13.3 | 902 | Common Stock $0.01 Par Value |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2020 | 600 | 0 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Sep 2020 | 600 | 4,341 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 505.02 per share. | 11 Sep 2020 | 298 | 4,043 (0%) | 0% | 505.0 | 150,496 | Bio-Rad A Common Stock |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2020 | 600 | 1,200 | - | - | Restricted Stock Units | |
| Bio-Rad Laboratories Inc. ... | Michael Crowley | EVP, GBL Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2020 | 600 | 3,273 (0%) | 0% | 0 | Bio-Rad A Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges